Sharon Bio-Medicine reports standalone net loss of Rs 75.79 crore in the September 2015 quarter

Sales decline 65.23% to Rs 112.99 crore

Net loss of Sharon Bio-Medicine reported to Rs 75.79 crore in the quarter ended September 2015 as against net profit of Rs 18.11 crore during the previous quarter ended September 2014. Sales declined 65.23% to Rs 112.99 crore in the quarter ended September 2015 as against Rs 324.92 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales112.99324.92 -65 OPM %3.8211.87 -PBDT-11.6825.65 PL PBT-16.6822.63 PL NP-75.7918.11 PL

Powered by Capital Market - Live News